Previously, we conducted a proteomic study showing that urinary soluble CD14 has diagnostic value as a strong predictor of RA disease activity (15); however, as far as we know, no study has conducted lipidomic analyses to identify biomarkers for RA. This evidence concerns the gene CD14 and rheumatoid arthritis.